Is UCB Scaling Back Its Indian Business?
This article was originally published in PharmAsia News
Executive Summary
Belgian drug maker UCB is said to be facing various headwinds in India. It is therefore reducing its exposure marking a big change from what it had at once described as a strategic emerging market.